Hedros Biotechnology
PrivateLast Round
Debt
May 28, 2024
Total Funding Raised
$425,000
Company Overview
Hedros Biotechnology is a biotechnology company that operates a research platform providing bacteriophages to fight bacterial infections, with a focus on disease control in aquaculture.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hedros Biotechnology Comparables
Compare Hedros Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phagos | 79% | |
| Proteon Pharmaceuticals | 78% | |
| NexaBiome | 77% |
Hedros Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | May 28, 2024 | ||||
| Accelerator | Jul 6, 2023 | ||||
| Accelerator | Jun 26, 2023 |
Hedros Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| North Carolina Biotechnology Center | Debt |
| Hatch Blue | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 28, 2024
$200K debt round from North Carolina Biotechnology Center
- Jul 6, 2023
Accelerator round led by Hatch Blue.
Hedros Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hedros Biotechnology's valuation, stock price, and market status.
Is Hedros Biotechnology a public or private company?
Hedros Biotechnology is a private company.
What is the current stock price of Hedros Biotechnology?
Hedros Biotechnology is a private company with no public stock price. No recent secondary market data is available.
How much is Hedros Biotechnology worth (valuation)?
Valuation information for Hedros Biotechnology is not publicly available.
Can I buy Hedros Biotechnology stock?
Hedros Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hedros Biotechnology's last funding round?
Hedros Biotechnology's most recent funding round was Debt on May 28, 2024.
Who are the main investors in Hedros Biotechnology?
Key investors in Hedros Biotechnology include Hatch Blue.
Will Hedros Biotechnology IPO soon?
No public IPO plans have been announced for Hedros Biotechnology.
How can I track Hedros Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hedros Biotechnology's secondary market activity and sign up for updates.